RegeneRx Biopharmaceuticals, Inc. announced the appointment of Alessandro Noseda M.D. to the Company's Board of Directors, effective April 1, 2019. He will be the sixth member of the Company's Board. Dr. Noseda is the Chief Scientific Officer of Leadiant Biosciences S.p.A. and has extensive scientific and medical experience in the global development of new medical technologies and drug products. He has held numerous managerial positions with the R&D and marketing organizations of multinational pharmaceutical companies during his career. Previously, Dr. Noseda was the Director of Scientific Office and Strategic Alliances with Sigma-Tau, where he managed key R&D projects and was involved in creating partnerships with Novartis and Debiopharm, among others. He has also been Chief Executive Officer of Leadiant Biosciences SA from 2007 to 2017.